Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.30
0.0000
Post-market: 1.30-0.0018-0.14%19:56 EDT
Volume:426.61K
Turnover:551.40K
Market Cap:33.15M
PE:-3.17
High:1.41
Open:1.36
Low:1.26
Close:1.30
52wk High:2.23
52wk Low:0.8500
Shares:25.50M
Float Shares:24.90M
Volume Ratio:0.76
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4100
EPS(LYR):-0.4071
ROE:-101.46%
ROA:-55.53%
PB:3.82
PE(LYR):-3.19

Loading ...

Jan 08, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jan 07, 2020

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Jan 02, 2020

Major Issues Report

[Amend] Current report, items 1.01, 3.02, and 9.01
Dec 23, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Dec 19, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Dec 17, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 17, 2019

[Amend]Public Prospectus

[Amend] General form for registration of securities under the Securities Act of 1933
Dec 13, 2019

Major Issues Report

Current report, items 5.07, 7.01, and 9.01
Nov 29, 2019

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Nov 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 06, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Sep 27, 2019

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Sep 26, 2019

Major Issues Report

Current report, items 5.03 and 9.01
Aug 23, 2019

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 01, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jun 10, 2019

Major Issues Report

Current report, items 5.02 and 9.01
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Sep 12, 2018

Major Issues Report

Apr 20, 2017

Correspondence

Apr 18, 2017

Correspondence